What are the FibroScan (transient elastography) cut‑offs for steatosis and fibrosis in adult patients with non‑alcoholic fatty liver disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

FibroScan Cut-offs for Fatty Liver Disease

For diagnosing advanced fibrosis (≥F3) in NAFLD patients, use a FibroScan cut-off of 7.1-7.9 kPa, which provides the highest diagnostic accuracy with an AUC of 0.90. 1

Fibrosis Staging Cut-offs

The most comprehensive 2024 meta-analysis of 19,199 patients established optimal cut-offs for vibration-controlled transient elastography (VCTE/FibroScan) across all fibrosis stages 1:

Recommended Cut-offs for Fibrosis:

  • ≥F2 (Significant fibrosis): 8.2 kPa 2
  • ≥F3 (Advanced fibrosis): 7.1-7.9 kPa (optimal range) 1 or 9.7 kPa 2
  • F4 (Cirrhosis): 13.6 kPa 2 to 14.4 kPa 3

The 7.1-7.9 kPa range for advanced fibrosis represents a slightly lower threshold than the traditional 8 kPa cut-off, reflecting updated evidence that maximizes diagnostic accuracy (AUC 0.90) 1. This lower threshold is particularly useful for ruling out advanced fibrosis and determining which patients need specialist referral.

Diagnostic Performance by Stage:

The 2024 guideline meta-analysis demonstrated excellent accuracy across stages 1:

  • ≥F1: AUC 0.83
  • ≥F2: AUC 0.83
  • ≥F3: AUC 0.87
  • F4: AUC 0.94

The accuracy improves substantially for advanced fibrosis and cirrhosis, making FibroScan most reliable for detecting these critical stages that determine prognosis and need for HCC surveillance.

Steatosis Grading Cut-offs

For quantifying hepatic fat using the Controlled Attenuation Parameter (CAP), the evidence supports these thresholds 2:

Recommended Cut-offs for Steatosis:

  • ≥S1 (≥5% steatosis): 302 dB/m (AUC 0.87)
  • ≥S2 (≥34% steatosis): 310-331 dB/m (AUC 0.77-0.82) 2, 4
  • S3 (>66% steatosis): 337 dB/m (AUC 0.70)

The CAP performs best at detecting any steatosis (≥S1) with sensitivity 89% and specificity 92% at 302 dB/m 2. However, accuracy decreases for higher grades of steatosis, with moderate performance for S3 (AUC 0.70) 2.

Important Clinical Considerations

Factors Affecting Accuracy:

For Liver Stiffness Measurement (LSM):

  • Elevated ALT levels can cause false-positive results for advanced fibrosis 5, 6
  • High BMI (≥30 kg/m²) may lead to overestimation of fibrosis 5
  • Fibrosis stage is the only histological parameter that significantly affects LSM; steatosis and probe type (M vs XL) do not independently influence readings 2

For CAP:

  • BMI ≥30 kg/m² is significantly associated with higher CAP values (>310 dB/m) 4
  • CAP accuracy is better in patients with established NASH compared to simple steatosis 4

Practical Algorithm:

  1. Initial screening: Use LSM with cut-off 7.1-7.9 kPa to identify advanced fibrosis risk
  2. If LSM <7.1 kPa: Advanced fibrosis unlikely; manage in primary care with lifestyle modification
  3. If LSM 7.1-9.7 kPa: Intermediate risk; consider additional markers (FIB-4, NFS) or repeat in 6-12 months
  4. If LSM ≥9.7 kPa: High probability of advanced fibrosis; refer to hepatology
  5. If LSM ≥13.6 kPa: Cirrhosis likely; urgent hepatology referral for HCC surveillance

Common Pitfalls to Avoid:

  • Do not interpret elevated LSM in isolation when ALT is >2x upper limit of normal; inflammation artificially raises stiffness 6
  • In obese patients (BMI ≥30), consider using XL probe and interpret borderline values cautiously 5
  • CAP values between 280-340 dB/m represent a "gray zone" for S2 steatosis with reduced specificity 2, 4
  • Remember that negative predictive value is higher than positive predictive value, making FibroScan better for ruling out rather than ruling in advanced disease 2

Alternative Technology:

For patients requiring higher accuracy or when FibroScan is indeterminate, MRI elastography (MRE) with cut-offs of 3.62-3.8 kPa for advanced fibrosis provides superior diagnostic performance (AUC 0.94) 1, though it is more expensive and less accessible.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.